Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $1.21 billion. The enterprise value is $844.65 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 326.05 million shares outstanding. The number of shares has increased by 26.02% in one year.
| Current Share Class | 326.05M |
| Shares Outstanding | 326.05M |
| Shares Change (YoY) | +26.02% |
| Shares Change (QoQ) | +10.04% |
| Owned by Insiders (%) | 8.07% |
| Owned by Institutions (%) | 77.25% |
| Float | 227.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 221.13 |
| Forward PS | 546.58 |
| PB Ratio | 3.40 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 153.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.56, with a Debt / Equity ratio of 0.15.
| Current Ratio | 18.56 |
| Quick Ratio | 18.42 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5,304.52 |
Financial Efficiency
Return on equity (ROE) is -54.18% and return on invested capital (ROIC) is -29.38%.
| Return on Equity (ROE) | -54.18% |
| Return on Assets (ROA) | -27.35% |
| Return on Invested Capital (ROIC) | -29.38% |
| Return on Capital Employed (ROCE) | -39.90% |
| Weighted Average Cost of Capital (WACC) | 10.98% |
| Revenue Per Employee | $55,404 |
| Profits Per Employee | -$1.58M |
| Employee Count | 99 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.23% in the last 52 weeks. The beta is 1.31, so TSHA's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -7.23% |
| 50-Day Moving Average | 4.35 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 34.73 |
| Average Volume (20 Days) | 2,873,098 |
Short Selling Information
The latest short interest is 53.48 million, so 16.40% of the outstanding shares have been sold short.
| Short Interest | 53.48M |
| Short Previous Month | 51.25M |
| Short % of Shares Out | 16.40% |
| Short % of Float | 23.53% |
| Short Ratio (days to cover) | 13.16 |
Income Statement
In the last 12 months, TSHA had revenue of $5.49 million and -$156.03 million in losses. Loss per share was -$0.42.
| Revenue | 5.49M |
| Gross Profit | 5.49M |
| Operating Income | -164.44M |
| Pretax Income | -156.03M |
| Net Income | -156.03M |
| EBITDA | -163.30M |
| EBIT | -164.44M |
| Loss Per Share | -$0.42 |
Full Income Statement Balance Sheet
The company has $422.83 million in cash and $54.59 million in debt, with a net cash position of $368.24 million or $1.13 per share.
| Cash & Cash Equivalents | 422.83M |
| Total Debt | 54.59M |
| Net Cash | 368.24M |
| Net Cash Per Share | $1.13 |
| Equity (Book Value) | 356.97M |
| Book Value Per Share | 1.10 |
| Working Capital | 403.11M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$140.94 million and capital expenditures -$716,000, giving a free cash flow of -$141.66 million.
| Operating Cash Flow | -140.94M |
| Capital Expenditures | -716,000 |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | n/a |
| Free Cash Flow | -141.66M |
| FCF Per Share | -$0.43 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,997.99% |
| Pretax Margin | -2,844.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.02% |
| Shareholder Yield | -26.02% |
| Earnings Yield | -11.19% |
| FCF Yield | -11.68% |
Analyst Forecast
The average price target for TSHA is $13.00, which is 249.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 249.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 142.30% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 9.08 and a Piotroski F-Score of 3.
| Altman Z-Score | 9.08 |
| Piotroski F-Score | 3 |